HIT Consultant January 26, 2022
What You Should Know:
– Philips introduced the industry’s first full-service, at-home, 12-lead electrocardiogram (ECG) solution for use in decentralized clinical trials.
– The solution is the most advanced patient-centric ECG offering within the company’s cardiac monitoring portfolio, pairing data readings comparable to clinical, site-based ECGs with Philips leading cloud-based data collection and analysis services.
Patient Attrition Issues
Patient attrition is one of the biggest issues faced by clinical trial sponsors and the inconvenience of adhering to protocol regimens and repetitive site visits is one of the top reasons why patients voluntarily choose to withdraw from a trial, beyond disease progression. A clinical-grade 12-lead ECG that patients can use in their own home as a part of decentralized clinical trials,...
Today's Sponsors
Today's Sponsor